Kyle Carver
Insider Reports History
- Location
- New York, NY
- Signature
- /s/ Gregory S. Moss, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Kyle Carver:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Evommune, Inc. | Chief Financial Officer | Common Stock | 62,510 | $1,115,178 | $17.84 | 09 Dec 2025 | Direct |
| Evommune, Inc. | Chief Financial Officer | Employee Stock Option (Right to Buy) | 279,408 | 05 Nov 2025 | Direct | ||
| Evommune, Inc. | Chief Financial Officer | Series B Preferred Stock | 0 | 07 Nov 2025 | Direct | ||
| Kadmon Holdings, Inc. | SVP, CAO, Controller | Common Stock | 0 | $9.50 | 09 Nov 2021 | Direct | |
| Kadmon Holdings, Inc. | SVP, CAO, Controller | Stock Option (right to buy) | 0 | $5.54 | 09 Nov 2021 | Direct |
Insider Reports Filed by Kyle Carver
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000175707225000010-carver-kyle-2025-12-09 | Evommune, Inc. | 09 Dec 2025 | 1 | -$237,094 | 4 | Chief Financial Officer | 11 Dec 2025, 16:20 |
| /report/000175707225000008-carver-kyle-2025-11-07 | Evommune, Inc. | 07 Nov 2025 | 2 | $0 | 4 | Chief Financial Officer | 12 Nov 2025, 16:16 |
| /report/000175707225000006-carver-kyle-2025-11-05 | Evommune, Inc. | 05 Nov 2025 | 1 | $0 | 4 | Chief Financial Officer | 07 Nov 2025, 16:15 |
| /report/000175707225000004-carver-kyle-2025-11-05 | Evommune, Inc. | 05 Nov 2025 | 0 | $0 | 3 | Chief Financial Officer | 05 Nov 2025, 20:01 |
| /report/000110465921136396-carver-kyle-2021-11-09 | Kadmon Holdings, Inc. | 09 Nov 2021 | 6 | -$2,523,590 | 4 | SVP, CAO, Controller | 09 Nov 2021, 16:36 |